Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Orlic-Milacic, Marija, 2017-12-04
| Class:Id | InstanceEdit:9031949 |
| _displayName | Orlic-Milacic, Marija, 2017-12-04 |
| _timestamp | 2017-12-04 16:57:12 |
| author | [Person:1169272] Orlic-Milacic, Marija |
| dateTime | 2017-12-04 21:55:28 |
| (modified) | [BlackBoxEvent:186773] PDGF dimer binds two receptors simultaneously [Homo sapiens] [Reaction:186819] SH2 domain of Src binds to the active receptor [Homo sapiens] [Complex:186831] PDGF:Phospho-PDGF receptor dimer:MyrG-SRC [plasma membrane] [Homo sapiens] [Complex:380768] PDGF:Phospho-PDGF receptor dimer:MyrG-p-Y419-SRC [plasma membrane] [Homo sapiens] [Reaction:380780] Activation of Src [Homo sapiens] [PathwayDiagram:469655] Diagram of Signaling by PDGF, Signaling by PDGFRA extracellular domain mutants, Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants, Signaling by cytosolic PDGFRA and PDGFRB fusion proteins, Signaling by membrane-tethered fusions of PDGFRA or PDGFRB, PDGFR mutants bind TKIs, Imatinib-resistant PDGFR mutants, Regorafenib-resistant PDGFR mutants, Sorafenib-resistant PDGFR mutants, and Sunitinib-resistant PDGFR mutants |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Orlic-Milacic, Marija, 2017-12-04 (9031949)